JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JVI Accepts, published online ahead of print on 16 January 2008
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JVI.02383-07v1
82/7/3391    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rehr, M.
Right arrow Articles by Oxenius, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rehr, M.
Right arrow Articles by Oxenius, A.

 Previous Article  |  Next Article 

J. Virol. doi:10.1128/JVI.02383-07
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Emergence of polyfunctional CD8+ T cells after prolonged suppression of HIV replication by antiretroviral therapy

Manuela Rehr, Julia Cahenzli, Anna Haas, David A. Price, Emma Gostick, Milo Huber, Urs Karrer, and Annette Oxenius*

Institute of Microbiology, ETH Hoenggerberg, Wolfgang-Pauli-Str. 10, 8093 Zurich, Switzerland; Department of Medical Biochemistry and Immunology, Cardiff University School of Medicine, Cardiff CF14 4XN, Wales, UK; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Raemistrasse 10, 8091 Zurich, Switzerland

* To whom correspondence should be addressed. Email: oxenius{at}micro.biol.ethz.ch.


   Abstract

Progressive HIV-1 infection is often associated with high plasma virus load (pVL) and impaired CD8+ T cell function; in contrast CD8+ T cells remain polyfunctional in long-term non progressors (LTNP). However, it is still unclear whether CD8+ T cell dysfunction is the cause or the consequence of high pVLs. Here, we conducted a longitudinal functional and phenotypic analysis of virus-specific CD8+ T cells in a cohort of patients with chronic HIV-1 infection. During the initiation and maintenance of successful antiretroviral therapy (ART), we assessed whether the level of pVL was associated with the degree of CD8+ T cell dysfunction. Under viremic conditions, HIV-specific CD8+ T cells were dysfunctional with respect to cytokine secretion (IFN{gamma}, IL2, TNF{alpha}) and their phenotype suggested limited potential for proliferation. During ART, cytokine secretion by HIV-specific CD8+ T cells was gradually restored, IL7R{alpha} and CD28 expression increased dramatically and PD-1 levels declined. Thus, prolonged ART-induced reduction of viral replication and hence presumably antigen exposure in vivo allows a significant functional restoration of CD8+ T cells with the appearance of polyfunctional cells. These findings indicate that the level of pVL as a surrogate for antigen load has a dominant influence on the phenotypic and functional profile of virus-specific CD8+ T cells.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.